Zero-Contrast Left Atrial Appendage Occlusion Using a Hybrid Echocardiography-Fluoroscopy Technique Without Iodinated

David I Blusztein1, Shawnbir Gogia1, Rebecca T Hahn1

  • 1Division of Cardiology, Columbia University Irving Medical Center, New York, New York.

Insights

Zero-contrast left atrial appendage occlusion is feasible and safe for patients with chronic kidney disease or allergies. This method achieved 100% procedural success without device complications in a small registry study.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Contrast media used in left atrial appendage occlusion may pose risks.
  • Patients with chronic kidney disease and allergies are particularly vulnerable to contrast-related complications.

Purpose of the Study:

  • To evaluate the feasibility and safety of a zero-contrast percutaneous left atrial appendage occlusion procedure.
  • To assess the efficacy of using echocardiography, fluoroscopy, and fusion imaging in a zero-contrast LAAO approach.

Main Methods:

  • A single-center registry study included 31 patients undergoing percutaneous left atrial appendage occlusion.
  • The procedure was performed without the use of iodinated contrast media.
  • Echocardiography, fluoroscopy, and fusion imaging were utilized for guidance.

Main Results:

  • The zero-contrast percutaneous left atrial appendage occlusion demonstrated 100% procedural success.
  • No device-related complications were observed in the 45-day follow-up period.
  • The technique proved feasible and safe in this cohort.

Conclusions:

  • Zero-contrast percutaneous left atrial appendage occlusion is a viable alternative for patients at risk from contrast media.
  • This approach minimizes risks associated with contrast agents in vulnerable patient populations.
  • Further research with larger cohorts is warranted to confirm these findings.